Toward a quantitative method for estimating tumour-stroma ratio in breast cancer using polarized light microscopy

被引:10
作者
Sprenger, Jillian [1 ]
Murray, Ciara [2 ]
Lad, Jigar [1 ]
Jones, Blake [1 ]
Thomas, Georgia [1 ]
Nofech-Mozes, Sharon [3 ]
Khorasani, Mohammadali [4 ]
Vitkin, Alex [1 ,5 ,6 ]
机构
[1] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[2] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[4] Univ British Columbia, Dept Surg, Victoria, BC, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Div Biophys & Bioimaging, Toronto, ON, Canada
[6] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
来源
BIOMEDICAL OPTICS EXPRESS | 2021年 / 12卷 / 06期
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
PROGNOSTIC-SIGNIFICANCE; INDEPENDENT PREDICTOR; SURVIVAL; CARCINOMA; TISSUE; CELLS;
D O I
10.1364/BOE.422452
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The tumour-stroma ratio (TSR) has been explored as a useful source of prognostic information in various cancers, including colorectal, breast, and gastric. Despite research showing potential prognostic utility, its uptake into the clinic has been limited, in part due to challenges associated with subjectivity, reproducibility, and quantification. We have recently proposed a simple, robust, and quantifiable high-contrast method of imaging intra- and peri-tumoural stroma based on polarized light microscopy. Here we report on its use to quantify TSR in human breast cancer using unstained slides from 40 patient samples of invasive ductal carcinoma (IDC). Polarimetric results based on a stromal abundance metric correlated well with pathology designations, showing a statistically significant difference between high- and low-stroma samples as scored by two clinical pathologists. The described polarized light imaging methodology shows promise for use as a quantitative, automatic, and standardizable tool for quantifying TSR, potentially addressing some of the challenges associated with its current estimation.
引用
收藏
页码:3241 / 3252
页数:12
相关论文
共 34 条
  • [1] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
    Albain, Kathy S.
    Barlow, William E.
    Shak, Steven
    Hortobagyi, Gabriel N.
    Livingston, Robert B.
    Yeh, I-Tien
    Ravdin, Peter
    Bugarini, Roberto
    Boehner, Frederick L.
    Davidson, Nancy E.
    Sledge, George W.
    Winer, Eric P.
    Hudis, Clifford
    Ingle, James N.
    Perez, Edith A.
    Pritchard, Kathleen I.
    Shepherd, Lois
    Gralow, Julie R.
    Yoshizawa, Carl
    Allred, D. Craig
    Osborne, C. Kent
    Hayes, Daniel F.
    [J]. LANCET ONCOLOGY, 2010, 11 (01) : 55 - 65
  • [2] [Anonymous], 2013, NONPARAMETRIC STAT M
  • [3] Tumor-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients
    Aurello, Paolo
    Berardi, Giammauro
    Giulitti, Diego
    Palumbo, Antonio
    Tierno, Simone Maria
    Nigri, Giuseppe
    D'Angelo, Francesco
    Pilozzi, Emanuela
    Ramacciato, Giovanni
    [J]. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2017, 15 (06): : 329 - 335
  • [4] Digital pathology and computational image analysis in nephropathology
    Barisoni, Laura
    Lafata, Kyle J.
    Hewitt, Stephen M.
    Madabhushi, Anant
    Balis, Ulysses G. J.
    [J]. NATURE REVIEWS NEPHROLOGY, 2020, 16 (11) : 669 - 685
  • [5] Mueller-matrix-based polarization imaging and quantitative assessment of optically anisotropic polycrystalline networks
    Borovkova, Mariia
    Trifonyuk, Larysa
    Ushenko, Volodymyr
    Dubolazov, Olexander
    Vanchulyak, Oleg
    Bodnar, George
    Ushenko, Yurii
    Olar, Olena
    Ushenko, Olexander
    Sakhnovskiy, Michael
    Bykov, Alexander
    Meglinski, Igor
    [J]. PLOS ONE, 2019, 14 (05):
  • [6] Browning L., 2020, J CLIN PATHOL
  • [7] Why the stroma matters in breast cancer Insights into breast cancer patient outcomes through the examination of stromal biomarkers
    Conklin, Matthew W.
    Keely, Patricia J.
    [J]. CELL ADHESION & MIGRATION, 2012, 6 (03) : 249 - 260
  • [8] Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
    de Kruijf, Esther M.
    van Nes, Johanna G. H.
    de Velde, Cornelis J. H. van
    Putter, Hein
    Smit, Vincent T. H. B. M.
    Liefers, Gerrit Jan
    Kuppen, Peter J. K.
    Tollenaar, Rob A. E. M.
    Mesker, Wilma E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) : 687 - 696
  • [9] Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
    Dekker, T. J. A.
    van de Velde, C. J. H.
    van Pelt, G. W.
    Kroep, J. R.
    Julien, J-P.
    Smit, V. T. H. B. M.
    Tollenaar, R. A. E. M.
    Mesker, W. E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 371 - 379
  • [10] The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
    Downey, C. L.
    Simpkins, S. A.
    White, J.
    Holliday, D. L.
    Jones, J. L.
    Jordan, L. B.
    Kulka, J.
    Pollock, S.
    Rajan, S. S.
    Thygesen, H. H.
    Hanby, A. M.
    Speirs, V.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (07) : 1744 - 1747